| Primary information |
|---|
| ID | antitb_1525, |
| Name | 25681127 |
| N-Terminal modification | N22 |
| C-Terminal Modification | VCEHIHLIRGLCHHLMHSYIKR |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 21 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Cell Line | Reduction in bacterial growth inhibiton to 59% at conc. Of 50 mg/L |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | Low toxicity to erythrocyte |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | |
| Combination Therapy | Inteacting with microbial membrane |
| Other activities | NA |
| PMID | NA |
| Year of Publication | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas |
Tertiary Structure
(Technique) | Not Predicted), |